These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19286462)

  • 1. Quantitative analysis of donepezil binding to acetylcholinesterase using positron emission tomography and [5-(11)C-methoxy]donepezil.
    Hiraoka K; Okamura N; Funaki Y; Watanuki S; Tashiro M; Kato M; Hayashi A; Hosokai Y; Yamasaki H; Fujii T; Mori E; Yanai K; Watabe H
    Neuroimage; 2009 Jul; 46(3):616-23. PubMed ID: 19286462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.
    Okamura N; Funaki Y; Tashiro M; Kato M; Ishikawa Y; Maruyama M; Ishikawa H; Meguro K; Iwata R; Yanai K
    Br J Clin Pharmacol; 2008 Apr; 65(4):472-9. PubMed ID: 18070217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.
    Gjerløff T; Jakobsen S; Nahimi A; Munk OL; Bender D; Alstrup AK; Vase KH; Hansen SB; Brooks DJ; Borghammer P
    J Nucl Med; 2014 Nov; 55(11):1818-24. PubMed ID: 25324520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
    Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
    Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of intravenously administered acetylcholinesterase inhibitor and acetylcholinesterase activity in the adrenal gland: 11C-donepezil PET study in the normal rat.
    Watabe T; Naka S; Ikeda H; Horitsugi G; Kanai Y; Isohashi K; Ishibashi M; Kato H; Shimosegawa E; Watabe H; Hatazawa J
    PLoS One; 2014; 9(9):e107427. PubMed ID: 25225806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the binding characteristics of [5-(11)C-methoxy]Donepezil in the rat brain for in vivo visualization of acetylcholinesterase.
    Funaki Y; Kato M; Iwata R; Sakurai E; Sakurai E; Tashiro M; Ido T; Yanai K
    J Pharmacol Sci; 2003 Feb; 91(2):105-12. PubMed ID: 12686754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic deficit and response to donepezil therapy in Parkinson's disease with dementia.
    Hiraoka K; Okamura N; Funaki Y; Hayashi A; Tashiro M; Hisanaga K; Fujii T; Takeda A; Yanai K; Iwata R; Mori E
    Eur Neurol; 2012; 68(3):137-43. PubMed ID: 22832236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography.
    Ota T; Shinotoh H; Fukushi K; Kikuchi T; Sato K; Tanaka N; Shimada H; Hirano S; Miyoshi M; Arai H; Suhara T; Irie T
    Clin Neuropharmacol; 2010; 33(2):74-8. PubMed ID: 19935404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.
    Gjerløff T; Fedorova T; Knudsen K; Munk OL; Nahimi A; Jacobsen S; Danielsen EH; Terkelsen AJ; Hansen J; Pavese N; Brooks DJ; Borghammer P
    Brain; 2015 Mar; 138(Pt 3):653-63. PubMed ID: 25539902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evaluation of [11C]donepezil as a tracer for visualization of acetylcholinesterase by PET.
    De Vos F; Santens P; Vermeirsch H; Dewolf I; Dumont F; Slegers G; Dierckx RA; De Reuck J
    Nucl Med Biol; 2000 Nov; 27(8):745-7. PubMed ID: 11150706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor.
    Bencherif B; Endres CJ; Musachio JL; Villalobos A; Hilton J; Scheffel U; Dannals RF; Williams S; Frost JJ
    Synapse; 2002 Jul; 45(1):1-9. PubMed ID: 12112408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503.
    Sakata M; Kimura Y; Naganawa M; Oda K; Ishii K; Chihara K; Ishiwata K
    Neuroimage; 2007 Mar; 35(1):1-8. PubMed ID: 17240168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies.
    Kim DH; Choe YS; Choi JY; Lee KH; Kim BT
    Nucl Med Biol; 2011 May; 38(4):541-7. PubMed ID: 21531291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of [
    Schildt A; de Vries EFJ; Willemsen ATM; Moraga-Amaro R; Lima-Giacobbo B; Sijbesma JWA; Sossi V; Dierckx RAJO; Doorduin J
    Mol Imaging Biol; 2020 Aug; 22(4):931-939. PubMed ID: 31907846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503.
    Ishikawa M; Sakata M; Ishii K; Kimura Y; Oda K; Toyohara J; Wu J; Ishiwata K; Iyo M; Hashimoto K
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1127-31. PubMed ID: 19573265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.
    Shinotoh H; Aotsuka A; Fukushi K; Nagatsuka S; Tanaka N; Ota T; Tanada S; Irie T
    Neurology; 2001 Feb; 56(3):408-10. PubMed ID: 11171913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPET.
    Ramakrishnan NK; Visser AK; Schepers M; Luurtsema G; Nyakas CJ; Elsinga PH; Ishiwata K; Dierckx RA; van Waarde A
    Psychopharmacology (Berl); 2014 Oct; 231(20):3997-4006. PubMed ID: 24639047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of (-)- and (+)-[¹¹C]galanthamine as PET tracers for cerebral acetylcholinesterase imaging.
    Kimura H; Kawai T; Hamashima Y; Kawashima H; Miura K; Nakaya Y; Hirasawa M; Arimitsu K; Kajimoto T; Ohmomo Y; Ono M; Node M; Saji H
    Bioorg Med Chem; 2014 Jan; 22(1):285-91. PubMed ID: 24315193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.